Schisandrin A Size:Solid 10 mg is a candidate therapeutic drug

is a candidate therapeutic drug for xerostomia in Sjogren's syndrome

Zetterlund A

1714146-59-4

and of TGF-beta-induced mitogen-activated protein kinase pathway components but does not alter ALK1

EtOH up to 10 mM

Schisandrin A Size:Solid 10 mg is a candidate therapeutic drugSchizandrin A, also known as Deoxyschizandrin, is a bio active isolate of Schisandra chinensis. Schizandrin A protects against cerebral ischemia reperfusion injury by suppressing inflammation and oxidative stress and regulating the AMPK Nrf2 pathway regulation. Schisandrin A prevents oxidative stress induced DNA damage and apoptosis by attenuating ROS generation in C2C12 cells. Product information CAS Number: 61281 38 7 Molecular Weight: 416. 51